IGF2 and ovarian carcinoma: Recently, the protein expression of IGF-II mRNA-binding protein 3 (IGF2BP3, also known as IMP3) was reported to be an independent marker for reduced disease-specific survival in the rarely studied clear cell carcinoma subtype of ovarian cancer [47].